World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: Netherlands Trial Register
Last refreshed on: 28 April 2013
Main ID:  NTR2552
Date of registration: 04/10/2010
Primary sponsor: Academic Medical Center (AMC)
Public title: Treatment planning techniques in pelvic irradiated patients.
Scientific title: Treatment planning techniques in pelvic irradiated patients. Comparison between 3D conformal and IMRT treatment planning techniques in supine and prone position in patients who receive pelvic irradiation. -
Date of first enrolment: 1/10/2010
Target sample size: 50
Recruitment status: recruiting
URL:  http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=2552
Study type:  observational
Study design:  Randomised: No; Masking: None; Control: Not applicable; Group: Parallel; Type: 2 or more arms, non-randomized  
Countries of recruitment
The Netherlands
Contacts
Name: G.H.  Westerveld
Address:  Meibergdreef 9, Academic Medical Center 1100 DD Amsterdam The Netherlands
Telephone:
Email: g.h.westerveld@amc.uva.nl
Affiliation: 
Name: G.H.  Westerveld
Address:  Meibergdreef 9, Academic Medical Center 1100 DD Amsterdam The Netherlands
Telephone:
Email: g.h.westerveld@amc.uva.nl
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Patients who are referred to our Radiotherapy department for pelvic irradiation for a gynaecologic or rectal malignancy;

2. Patients should be able to lie in prone position on a belly-board.

Exclusion criteria: 1. Unable to lie on a belly-board;

2. Allergic to iv-contrast;

3. Kidney failure (calculated GFR < 60ml/min);

4. Need for irradiation of the para-aortic lymph nodes.


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Radiotherapy, Rectal cancer, Prone position, Gynaecologic tumor, Small intestine, Toxicity, Organs at risk

Intervention(s)
One extra CT scan before start radiotherapy.
Primary Outcome(s)
1. Coverage of the PTV;

2. Dmean of the small bowel (mean dose in the small bowel);

3. V15 and V45 of the small bowel (volume of the small bowel which receives respectively 15 and 45Gy).
Secondary Outcome(s)
1. Dmean of the bladder, kidneys, sigmoid and, in case of gynaecologic patients, rectal wall;

2. V25, V30, V35, V40 and V50 of the small bowel (volume which receives respectively 25, 30, 35, 40 and 50 Gy).
Secondary ID(s)
10/188 / NL33187.018.10 ;
Source(s) of Monetary Support
Academic Medical Center (AMC), Department of Radiotherapy
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history